Epilepsy, Tonic-Clonic: Clinical Trials

23 trials for Epilepsy, Tonic-Clonic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 9 Phase 3, 7 Not applicable, 3 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 39Completed 6, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1
Not applicable7Completed 6, Terminated 1
Phase 43Completed 2, Recruiting 1
Phase 11Completed 1

Follow Epilepsy, Tonic-Clonic: new trials by email Literature Review of Epilepsy, Tonic-Clonic trials Research Report on Epilepsy, Tonic-Clonic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Levetiracetam 500mg, Placebo - Down Syndrome, Down Syndrome (DS)
Phase 3RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1202025-12-222026-01-12
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
vormatrogine - Epilepsy, Tonic-Clonic, Focal Seizure
Phase 3Enrolling by invitationPraxis Precision Medicines7002025-10-272026-08-03
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Oral Zonisamide Therapy - Epilepsies, Partial, Epilepsy, Tonic-Clonic
Phase 4RecruitingAffiliated Hospital of Nantong University302024-08-012025-05-13
RNS System NAUTILUS Study
Responsive stimulation, Sham stimulation - Epilepsy, Idiopathic Generalized Epilepsy
Not applicableCompletedNeuroPace1002022-08-092026-06-08
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
Fenfluramine, Placebo - CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure
Phase 3Active not recruitingZogenix, Inc.872022-03-082026-04-29
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
STARSTIM device, Sham Device - Refractory Epilepsy, Focal Seizure
Not applicableCompletedNeuroelectrics Corporation1272021-10-252026-04-08
EpiWatch: Evaluation of a Non-EEG Physiological Signal Based Seizure Monitoring System
Physiological signal monitoring and seizure detection - Epilepsy, Tonic-Clonic
Not applicableCompletedEpiWatch, Inc.2422021-09-202025-02-04
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
Perampanel - Idiopathic Generalized Epilepsy, Partial Onset Seizures
CompletedEisai Limited1912020-07-202023-02-09
XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
Accelerometer Live-Streaming Tool - Epilepsy, Tonic-Clonic
WithdrawnLivaNova2020-03-162020-08-25
Embrace and Quality of Life
Embrace with Alert and Mate apps, Embrace with Mate app only - Epilepsy, Tonic-Clonic
Not applicableTerminatedCentre Hospitalier Universitaire Vaudois262018-10-102022-07-22
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
Microburst Stimulation - Epilepsies, Partial, Epilepsy, Tonic-Clonic
Not applicableCompletedLivaNova332018-02-272022-10-25
Novel Helmet Design in Patients With Seizures
Hövding inflatable helmet - Drug Resistant Epilepsy, Drop Seizures
Not applicableCompletedMichael A. Gelfand, MD, PhD92017-08-142025-01-09
Topiramate Bioequivalence Study Brazil - Fast
Topiramate coated tablet, Topamax® coated tablet - Epilepsy, Tonic-Clonic
Phase 1CompletedGlaxoSmithKline262011-07-222017-06-28
Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy
T-VNS® Stimulator cM02 (Transcutaneous Stimulation of the Vagus Nerve) - Epilepsy
Not applicableCompletedcerbomed GmbH72009-08-012011-03-08
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
Keppra, Fosphenytoin, Dilantin - Tonic-clonic Seizure
Phase 4CompletedEmory University1582007-07-012013-12-12
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
Levetiracetam - Epilepsy, Tonic-clonic
Phase 3CompletedUCB Pharma SA662005-08-102018-11-21
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
lamotrigine (LAMICTAL) extended-release, Placebo - Epilepsy, Tonic-Clonic
Phase 3CompletedGlaxoSmithKline1532004-12-012017-01-02
Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
LEVETIRACETAM - Epilepsy, Tonic-clonic
Phase 3CompletedUCB Pharma2502003-07-012013-11-26
Evaluation and Treatment of Patients With Epilepsy
Epilepsy
TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)12782001-05-012019-12-12
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
lamotrigine - Epilepsy, Tonic-Clonic
Phase 4CompletedGlaxoSmithKline1412000-12-012017-04-04

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Epilepsy (15)  ·  Seizures (15)  ·  Epilepsies, Partial (3)  ·  Drug Resistant Epilepsy (2)  ·  Epilepsy, Idiopathic Generalized (2)  ·  Alzheimer Disease (1)  ·  CDKL5 deficiency disorder (1)  ·  Dementia (1)  ·  Down Syndrome (1)  ·  Emergencies (1)  ·  Epilepsy, Absence (1)  ·  Epilepsy, Frontal Lobe (1)  ·  Epilepsy, Generalized (1)  ·  Epilepsy, Temporal Lobe (1)

Broader conditions

Brain Diseases (23)  ·  Central Nervous System Diseases (23)  ·  Nervous System Diseases (23)  ·  Epilepsy, Generalized (22)  ·  Neurologic Manifestations (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Signs and Symptoms (15)  ·  Epilepsy (8)  ·  Epileptic Syndromes (3)  ·  Neurobehavioral Manifestations (2)  ·  Abnormalities, Multiple (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Consciousness Disorders (1)

Interventions

Levetiracetam (4)  ·  Topiramate (3)  ·  Lamotrigine (2)  ·  Fenfluramine (1)  ·  Phenytoin (1)  ·  fosphenytoin (1)  ·  perampanel (1)

Sponsors

GlaxoSmithKline (3)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3)  ·  LivaNova (2)  ·  Affiliated Hospital of Nantong University (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Eisai Limited (1)  ·  Emory University (1)  ·  EpiWatch, Inc. (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Michael A. Gelfand, MD, PhD (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  NeuroPace (1)  ·  Neuroelectrics Corporation (1)  ·  Praxis Precision Medicines (1)  ·  UCB Pharma (1)

Countries

United States (11)  ·  Germany (5)  ·  Spain (5)  ·  Belgium (4)  ·  Brazil (3)  ·  Italy (3)  ·  Argentina (2)  ·  Chile (2)  ·  France (2)  ·  Poland (2)  ·  Portugal (2)  ·  Russia (2)  ·  Austria (1)  ·  China (1)  ·  Czechia (1)

Top investigators

Debra Houry, MD (1)  ·  Gregory L Krauss, MD (1)  ·  Krisl Vonck (1)  ·  Martha Morrell, MD (1)  ·  Michael Gelfand, MD, PhD (1)  ·  Sara K Inati, M.D. (1)  ·  Selim Benbadis, MD (1)  ·  Stefan Herrmann, MD (1)

Results publications

PMID 10227614, PMID 10768306, PMID 16344515, PMID 17283312, PMID 20937567, PMID 37384278, PMID 38499287, PMID 38532258

NIH funding

2023 (1)